Annual report pursuant to Section 13 and 15(d)

Income taxes (Tables)

v3.24.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Reconciliation of Federal Statutory Income Tax Provision To Company's Actual Provision
A reconciliation of the federal statutory income tax provision to our actual provision for the years ended December 31, 2023 and 2022 is as follows:
  2023 2022
Pre-tax book income (loss) $ (4,490,665) $ (2,381,360)
Expected tax at 21%
(943,040) (500,086)
Permanent differences:
Mark to market —  (3,937)
Intangible amortization (46,373) (89,480)
Other 6,474  2,404 
State taxes:
Current 32,491  16,352 
Deferred (264,759) (162,688)
Other items:
Federal research and development credits (84,592) (7,647)
Deferred tax past year true-up's (63,440) (46,786)
Change in valuation allowance 980,342  668,326 
Capitalized research and development expenses 334,120  174,674 
Other 81,268  (34,780)
Income tax provision $ 32,491  $ 16,352 
Schedule of Deferred Tax Assets
The components of net deferred tax assets recognized in the accompanying consolidated balance sheets at December 31, 2023 and 2022 are as follows:
  2023 2022
Net operating loss carryforwards $ 10,840,000  $ 9,812,000 
R&D and ITC credit carryforwards 403,000  310,000 
Accrued expenses and other 381,000  317,000 
Intangibles 486,000  342,000 
Leases 8,000  17,000 
Accounts receivable 39,000  96,000 
Stock options 450,000  386,000 
Inventory 427,000  366,000 
Property, plant and equipment 650,000  705,000 
Other 323,000  342,000 
Deferred tax assets 14,007,000  12,693,000 
Valuation allowance (14,007,000) (12,693,000)
Deferred tax assets, net $ —  $ —